These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 66315)

  • 1. Fluorinated Pyrimidine nucleosides. 1. Synthesis of a nitrogen analogue of the antitumor agent 2,2'-anhydro-1-beta-D-arabinofuranosyl-5-fluorocytosine hydrochloride.
    Cook AF
    J Med Chem; 1977 Mar; 20(3):344-8. PubMed ID: 66315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic effects of the combination of cis-platinum diamminodichloride and 2,2'-anhydro-1-beta-D-arabinofuranosyl-5-fluorocytosine in transplanted mouse leukemias.
    Burchenal JH; O'Toole T; Kalaher K; Chisholm J
    Cancer Res; 1977 Nov; 37(11):4098-100. PubMed ID: 71204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of tissue distribution and fate of 2,2'-anhydro-1-beta-D-arabinofuranosyl-5-fluorocytosine and 1-beta-D-arabinofuranosyl-5-fluorocytosine in rats.
    Chou TC; Vidal P; Phillips FS
    Cancer Treat Rep; 1977 Jul; 61(4):617-24. PubMed ID: 69496
    [No Abstract]   [Full Text] [Related]  

  • 4. Phase II study of 2,2'-anhydro-1-beta-D-arabinofuranosyl-5-fluorocytosine in advanced colorectal carcinoma.
    Kemeny N; Yagoda A; Burchenal JH
    Cancer Treat Rep; 1978 Mar; 62(3):463-4. PubMed ID: 77190
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of 2,2'-anhydro-1-beta-D-arabinofuranosyl-5-fluorocytosine and cytosine arabinoside in the treatment of murine brain tumor.
    Basler GA; Shapiro WR
    Cancer Treat Rep; 1976 Jul; 60(7):875-9. PubMed ID: 64295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Studies on biologically active nucleosides and nucleotides. 5. Synthesis and antitumor activity of some 2,2'-anhydro-1-(3',5'-di-O-acyl-beta-D-arabinofuranosyl)cytosine salts and 2,2'-anhydro-1-(3'-O-acyl-beta-D-arabinofuranoxyl)cytosine 5'-phosphates.
    Kondo K; Nagura T; Arai Y; Inoue I
    J Med Chem; 1979 Jun; 22(6):639-46. PubMed ID: 458820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 1-(2,3-Anhydro-beta-D-lyxofuranosyl)cytosine derivatives as potential inhibitors of the human immunodeficiency virus.
    Webb TR; Mitsuya H; Broder S
    J Med Chem; 1988 Jul; 31(7):1475-9. PubMed ID: 2455053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and antitumor and antiviral activities of 1-beta-D-arabinofuranosyl-2-amino-1,4(2H)-iminopyrimidine and its derivatives.
    Mian AM; Long RA; Allen LB; Sidwell RW; Robins RK; Khwaja TA
    J Med Chem; 1979 May; 22(5):514-8. PubMed ID: 458802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of 2,2'-anhydro-1-(3'-Ok-acetyl-beta-D-arabinofuranosyl)-5-iodocytosine hydrochloride and related compounds as antineoplastic and antiviral agents.
    Itoh YH; Chu MY; Chang PK; Allaudeen HS; Sartorelli AC
    Chem Biol Interact; 1981 Jan; 33(2-3):215-27. PubMed ID: 6257405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anhydro-ara-5-fluorocytidine (AAFC) in gastrointestinal cancer. A phase II study.
    Falkson G; Falkson HC; du Plessis HE; Meyer TE
    Cancer Clin Trials; 1980; 3(4):341-4. PubMed ID: 6159121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 6-Substituted 2,4-diaminopyrido[3,2-d]pyrimidine analogues of piritrexim as inhibitors of dihydrofolate reductase from rat liver, Pneumocystis carinii, and Toxoplasma gondii and as antitumor agents.
    Gangjee A; Zhu Y; Queener SF
    J Med Chem; 1998 Nov; 41(23):4533-41. PubMed ID: 9804692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and antitumor activity of 1-beta-4-selenoarabinofuranosyl cytosine (4'-seleno-ara-C).
    Lee H; Tosh DK; Choi WJ; Kim YM; Lee SK; Jeong LS
    Nucleic Acids Symp Ser (Oxf); 2008; (52):639-40. PubMed ID: 18776542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of acute nonlymphocytic leukemia in adults: response to 2,2-anhydro-1-B-D-arabinofuranosyl-5-fluorocytosine and thioguanine on the L-12 protocol.
    Mertelsmann R; Drapkin RL; Gee TS; Kempin S; Passe S; Thaler HT; Arlin Z; Dowling M; Dufour P; McKenzie S; To L; Comacho E; Oettgen HF; Burchenal JH; Clarkson B
    Cancer; 1981 Nov; 48(10):2136-42. PubMed ID: 6170414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II study of anhydro-ara-5-fluorocytidine in adenocarcinoma of gastrointestinal tract, epidermoid carcinoma of lung, head and neck, breast carcinoma and small cell anaplastic carcinoma of lung. A study report of the E.O.R.T.C. early clinical trial cooperative group.
    Alberto P; Rozencweig M; Gangji D; Brugarolas A; Cavalli F; Siegenthaler P; Hansen HH; Sylvester R
    Eur J Cancer (1965); 1978 Feb; 14(2):195-201. PubMed ID: 75105
    [No Abstract]   [Full Text] [Related]  

  • 15. Diaziquone and 2,2'-anhydro-arabinosyl-5-fluorocytosine for the treatment of children with relapsed or refractory acute nonlymphoblastic leukemia.
    Meyers PA; Tan CT; Steinherz PG; Redner A
    Cancer; 1989 Dec; 64(12):2416-9. PubMed ID: 2479459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleosides and nucleotides. 95. Improved synthesis of 1-(2-azido-2-deoxy-beta-D-arabinofuranosyl)cytosine (cytarazid) and -thymine. Inhibitory spectrum of cytarazid on the growth of various human tumor cells in vitro.
    Matsuda A; Yasuoka J; Sasaki T; Ueda T
    J Med Chem; 1991 Mar; 34(3):999-1002. PubMed ID: 2002478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleosides and nucleotides. 122. 2'-C-cyano-2'-deoxy-1-beta-D-arabinofuranosylcytosine and its derivatives. A new class of nucleoside with a broad antitumor spectrum.
    Azuma A; Nakajima Y; Nishizono N; Minakawa N; Suzuki M; Hanaoka K; Kobayashi T; Tanaka M; Sasaki T; Matsuda A
    J Med Chem; 1993 Dec; 36(26):4183-9. PubMed ID: 8277499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nucleosides. XCI. Some chemical properties of the antileukemic agent 2,2'-anhydro-1-beta-D-arabinofuranosyl-5-fluorocytosine.
    Fox JJ; Otter BA
    Ann N Y Acad Sci; 1975 Aug; 255():59-70. PubMed ID: 1059375
    [No Abstract]   [Full Text] [Related]  

  • 19. Physiological disposition of 2,2'-anhydro-1-beta-D-arabinofuranosyl-5-fluorocytosine in humans.
    Kreis W; Gordon CS; DeJager R; Krakoff IH
    Cancer Res; 1975 Sep; 35(9):2453-60. PubMed ID: 1149046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antitumor activity of certain 3-beta-D-ribofuranosyl-1,2,4-triazolo[3,4-f]-1,2,4-triazines related to formycin prepared via ring closure of a 1,2,4-triazine precursor.
    Ramasamy K; Ugarkar BG; McKernan PA; Robins RK; Revankar GR
    J Med Chem; 1986 Nov; 29(11):2231-5. PubMed ID: 3783585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.